Skip to content

Comparative Evaluation of Laser assisted Ablative Versus Non-ablative Gingival Depigmentation: A Randomized Clinical Trial

Comparative Evaluation of Laser assisted Ablative Versus Non-ablative Gingival Depigmentation : A Rabdomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094021
Enrollment
30
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Laser assisted Non-Ablative Gingival Depigmentation Procedure: Laser assisted Non-Ablative Gingival Depigmentation Procedure employed the use of 445 nm wavelength, power of 0.9 watt, in

Sponsors

Saraswati Dental College & Research Centre
Lead Sponsor
Shruti singh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 18 to 35 years of age

Exclusion criteria

Exclusion criteria: 1.The gingival hyperpigmentation that is secondary as a result of a systemic/ congenital condition/ disorder e.g. McCune Albright syndrome, Hutchinson Gilford Progeria Syndrome, Dyskeratosis congentia, Familial Progressive hyperpigmentation etc. 2. Participants with gingival hyperpigmentation due to the use of medications e. g. tetracycline. 3. Participants who were chronic smokers (self-reported) 4. Participants contraindicated for laser therapy (with phototoxicity, oral malignancy)

Design outcomes

Primary

MeasureTime frame
clinician reported outcomes (Dummet-Gupta oral pigmentation Index, Melanin Index, Gingival Pigmentation IndexTimepoint: Baseline, 1 week, 1 month and 3 months.

Secondary

MeasureTime frame
Patient Post Surgical Discomfort Score, Patient Satisfaction Score, Patient Esthetic ScoreTimepoint: Baseline, 1 week, 1 month and 3 month;Patient Post Surgical Discomfort Score (PPSDS), Patient Esthetic Score (PES), Patient Satisfaction Score (PSS)Timepoint: PPSDS- 24 hours after intervention PES- Baseline, 1 week, 1 month and 3 months PSS- 1 week, 1 month, 3 months.

Countries

India

Contacts

Public ContactShruti Singh

Saraswati Hospital & Research Centre

shrutisingh22624@gmail.com8707698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026